Exagen Inc. (XGN) reported second-quarter 2026 revenue of $19.9 million, up 16% from the second quarter of 2025. The company reported a net loss of $3.2 million, compared with a net loss of $4.4 million a year earlier.
Exagen increased its full-year 2026 revenue guidance to $72 million to $75 million, compared with prior guidance of $70 million to $73 million. The company said it ended the quarter with about $25 million in cash and cash equivalents.
- Second-quarter revenue was $19.9 million, compared with $17.2 million in the prior-year quarter.
- Net loss per share, basic and diluted, was $0.13, compared with $0.21 a year earlier.
- AVISE CTD test volume rose 11% from the second quarter of 2025.
- Trailing twelve-month average selling price was $446 per test, up $18 per test from a year earlier.
- Adjusted EBITDA loss was $0.1 million, compared with a loss of $1.7 million in the second quarter of 2025.
$XGN Insider Trading Activity
$XGN insiders have traded $XGN stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $XGN stock by insiders over the last 6 months:
- JOHN ABALLI (President and CEO) has made 0 purchases and 2 sales selling 27,128 shares for an estimated $98,089.
- JEFFREY G. BLACK (Chief Financial Officer) sold 1,584 shares for an estimated $5,718
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$XGN Hedge Fund Activity
We have seen 23 institutional investors add shares of $XGN stock to their portfolio, and 44 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RTW INVESTMENTS, LP removed 395,231 shares (-50.0%) from their portfolio in Q1 2026, for an estimated $1,185,693
- NANO CAP NEW MILLENNIUM GROWTH FUND L P added 335,000 shares (+134.0%) to their portfolio in Q1 2026, for an estimated $1,005,000
- WEXFORD CAPITAL LP added 326,077 shares (+69.9%) to their portfolio in Q1 2026, for an estimated $978,231
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 277,837 shares (-91.6%) from their portfolio in Q1 2026, for an estimated $833,511
- ACADIAN ASSET MANAGEMENT LLC added 274,666 shares (+66.3%) to their portfolio in Q1 2026, for an estimated $823,998
- MARSHALL WACE, LLP removed 216,135 shares (-88.8%) from their portfolio in Q1 2026, for an estimated $648,405
- TWO SIGMA INVESTMENTS, LP removed 210,429 shares (-57.1%) from their portfolio in Q1 2026, for an estimated $631,287
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
